Global beauty company APAR has confirmed that its MediCube 'PDRN Pink Collagen Capsule Cream' showed no traces of Sudan Red in official tests. The company stated that further verification is needed regarding the authenticity and distribution of the questioned product.
On September 3, APAR responded to the announcement by Singapore's Health Sciences Authority (HSA), which reported that traces of Sudan Red were detected in some batches of the MediCube PDRN Pink Collagen Capsule Cream.
The batch numbers identified by HSA with trace amounts of Sudan Red are 2E122I.2E117I and 2E191G.2E193G. APAR explained that after reviewing official shipping and export records, there is no export history of these batches to Singapore. Therefore, verification of the product's authenticity and the distribution channels through local vendors in Singapore is necessary.
APAR also clarified that it has no record of supplying or exporting the product to Venus Beauty Pte. Ltd., the retailer mentioned by HSA. According to the official shipping and export records reviewed by the company, Venus Beauty is not included in the official supply and distribution channels, and the batch numbers disclosed by HSA are not found in Singapore's official export records.
On August 3, APAR conducted separate product testing in Singapore at the request of HSA, which confirmed that no Sudan Red was detected. Subsequently, on August 26, APAR received notification from HSA that the suspension of sales and supply for the product had been lifted.
An APAR representative stated, "Since the issue arose, we have prioritized consumer safety by proactively halting sales in Asia and responding diligently to requests from authorities. After confirming the absence of Sudan Red in tests conducted by HSA-accredited laboratories, the suspension of sales and supply was lifted."
The representative added, "The retailer mentioned by HSA as the source of the detected samples is not one of our official distributors, and the batch in question is also not found in our official export records to Singapore. We are verifying the factual circumstances surrounding how the product was distributed locally based on objective data."
Meanwhile, APAR reported a consolidated revenue of 767.5 billion won for the second quarter of this year, marking a 134.2% increase compared to the same period last year. MediCube has consistently ranked first in the beauty category during Amazon's Prime Day in the first and second quarters of this year.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.